Page results
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
This service provides a tertiary level, second opinion service, specialising in the diagnostic assessment and treatment of complex speech sound disorders. The team has particular expertise in Childhood Apraxia of Speech (CAS).
-
Bones marrow harvest patient information page.
-
Online talk on diet for people having cancer care at UCLH
-
Online workshop for people having care for cancer or a blood condition at University College London Hospitals
-
Here you find all of our information leaflets which will help with day to day diabetes management including managing highs and lows, sick day rules and managing school days including the most up to date school care plans. You will also find information on how to upload your devices at home.
-
An advertising campaign has launched in north London to encourage people to take up a free NHS lung health check, provided by UCLH. Campaign posters will be on a number of bus shelters in Barnet, Camden, Enfield, Haringey and Islington, selected underground stations and online until the end of November.
-
Komal Khuti-Dullaart is one of more than 300,000 patients using MyCare UCLH, our app and online service to help manage patient care.
-
UCLH clinical trial practitioner Antonette Andrews was amazed to learn that her great aunt came to the UK as part of the Windrush Generation and joined the NHS, where Antonette works today.
File results
-
FOI/2023/0386 - Sickle Cell staffing and patients
-
FOI/2023/0384 - Cyber security attacks 2020-2022
-
FOI/2023/0383 - Cataract referrals
-
FOI/2023/0380 - Flexible nurse bank rates/ spend March 2023
-
FOI/2023/0379 - MDT meetings in relation to tailgut cysts
-
FOI/2023/0376 - Director of Estate and Facilities/ Head of Patient Experience contact details
-
FOI/2023/0082 - Organisation structure for Performance and Planning department
-
FOI/2023/0081 - Biometric technology wearables/ data collection
-
FOI/2023/0080 - Treatment for Myeloid leukaemia (AML) and chronic lymphocytic leukaemia
-
FOI/2023/0083 - Software systems/ suppliers used at Trust